 |
Breast Cancer |
 |
The Improved Outlook for Breast Cancer: The Role of Aromatase Inhibitors
The survival rate for breast cancer has improved over the years, due in part to earlier detection, but also because of better treatments. See how hormonal treatments have helped women with certain types of breast cancer live longer with the disease.
>> Watch Video
>> Read Transcript
|
|
|
|
|
|
Hormonal Treatments for Breast Cancer: Do Side Effects Matter?
Battling breast cancer is hard enough without battling treatment side effects as well. Learn how to maintain a good quality of life and still fight your disease.
>> Watch Video
>> Read Transcript
|
|
|
|
|
|
|
Treatment after Tamoxifen for Breast Cancer
Many women have reaped the benefits of the breast cancer drug tamoxifen. Now a new study has shown that other drugs may pick up where tamoxifen leaves off, keeping breast cancer from coming back.
>> Watch Video
>> Read Transcript
|
|
|
|
|
|
|
What Do I Do After Tamoxifen?
Some women with breast cancer receive tamoxifen to prevent the cancer's return. Learn how the results of a new study may change the future of breast cancer treatment.
>> Watch Video
>> Read Transcript
|
|
|
|
|
|
|
Breast Cancer Treatment: Using Aromatase Inhibitors after Tamoxifen
Fighting breast cancer can mean using a variety of strategies. The good news is that even after one strategy loses its power against the disease, there may be other treatments that can continue the battle. For over 30 years a drug called tamoxifen has been traditionally the first drug used in women with hormone receptor positive breast cancer. Now, doctors can offer other drugs that can successfully continue to fight the cancer.
>> Watch Video
>> Read Transcript
|
|
|
|
|
|
|
Accolades for New Breast Cancer Treatment: Study Results Released
In the middle of this year's Breast Cancer Awareness Month, women with breast cancer will hear some encouraging news about treatment. A hormonal therapy called letrozole, also known as Femara, may reduce the risk of breast cancer recurrence.
>> Read Article
|
|
Bone Complications in Breast Cancer
Sometimes breast cancer can spread to bone. Tune in as experts discuss treatments that reduce pain and prevent bone complications in people with breast cancer.
>> Watch Video
>> Read Transcript
|
|
Bright Future For Breast Cancer Hormonal Therapy
A new class of drugs called aromatase inhibitors is making waves as a first-line treatment for advanced breast cancer that is sensitive to estrogen. These drugs slve the problem of drug resistance by stopping estrogen production altogether in postmenopausal women.
>> Read Article
|
|
The Silence of Breast Cancer in Hispanic and Latino World
Breast cancer is less common among Hispanic/Latino women than among Caucasians and African-Americans. That may sound like good news, but their five-year survival rates remain lower than those in other ethnic groups.
>> Read Article
|
|
Hormone Therapies Dampen Estrogen's Hold on Advanced Cancer
While the hormone estrogen serves many important functions in a woman's body, is also the very thing that some breast cancer cells need to multiply. Approximately two-thirds of women have breast cancer that is "hormone-receptor positive", which makes them good candidates for hormonal therapy.
>> Read Article
|
|
The Future of Breast Cancer Detection
Great strides have been made in breast cancer screening in recent years. New approaches include digital mammography, in which a computer enhances mammogram images, and a technique in which cells are removed from the breast ducts, and tested for cancer.
>> Read Article
|
|
It's Not Over: Life After Breast Cancer
It's often assumed that coping with the shock of a breast cancer diagnosis is the most difficult part of living with breast cancer, but new challenges arise after treatment ends. Learn what comes next.
>> Read Article
|
|
Breast Cancer Treatment Side Effects Come Center Stage
While there's never a good time to get breast cancer, women diagnosed today tend to have less debilitating treatment experiences than women who were diagnosed 10 years ago.
>> Read Article
|
|
|
Current Developments In 
